NASDAQ:SNES Stock Quote
Senestech Inc is a biotechnology company focused on the development of innovative solutions for pest control through its proprietary platform that employs the principles of biology and technology
The company's primary aim is to create environmentally friendly products that effectively manage pest populations while minimizing harmful impacts on non-target species and ecosystems. By utilizing a unique approach to target specific species, Senestech seeks to meet the growing demand for sustainable pest management solutions in various agricultural and residential markets.
Frequently Asked Questions
Are there any partnerships or collaborations SenesTech is known for?
SenesTech has engaged in various partnerships and collaborations to advance its product development and market reach. Collaborative efforts with agricultural organizations, wildlife agencies, and research institutions aim to enhance the efficacy of their solutions and gather real-world data on their pest management practices.
How can I invest in SenesTech, Inc.?
To invest in SenesTech, Inc., individuals can purchase shares through a brokerage account as the company is publicly traded under the ticker symbol SNES. Potential investors should conduct their due diligence, considering the company's performance, market position, and future growth opportunities before investing.
How does ContraPest work?
ContraPest works by affecting the reproductive system of female rodents, specifically disrupting the hormonal signals involved in ovulation. When consumed, it causes a temporary infertility effect, leading to population control over time as fewer offspring are produced, thereby aiming to stabilize and reduce rodent populations humanely.
How does SenesTech ensure the safety of its products?
SenesTech ensures the safety of its products by conducting extensive research and clinical trials that comply with regulatory standards. The development process involves rigorous safety assessments to evaluate potential impacts on non-target species and the overall ecosystem, ensuring that products like ContraPest are both effective and environmentally responsible.
How does SenesTech plan to grow its market presence?
SenesTech plans to grow its market presence through strategic partnerships, educational campaigns to raise awareness about the benefits of humane pest management, and continued research and development of its product line. Expanding distribution channels and exploring international markets are also key strategies for growth.
Is SenesTech publicly traded?
Yes, SenesTech, Inc. is publicly traded on the Nasdaq stock exchange under the ticker symbol SNES. The company went public to raise capital for further research and development as well as to expand its market reach.
What are the benefits of using ContraPest compared to traditional rodenticides?
The benefits of using ContraPest compared to traditional rodenticides include its non-lethal approach to pest management, decreased risk of secondary poisoning to non-target wildlife, and reduction of rodent populations over time through fertility control. This method also aligns with sustainable agricultural practices and enhances public perception of pest management solutions.
What challenges does SenesTech face?
SenesTech faces several challenges, including regulatory hurdles, competition from traditional pest control methods, and the need for widespread customer education on its non-lethal approach. Additionally, gaining acceptance from consumers and stakeholders in industries reliant on conventional rodent control solutions poses an ongoing challenge.
What does SenesTech, Inc. do?
SenesTech, Inc. is a biotechnology company focused on the development of innovative technologies for managing animal populations. Primarily, the company's flagship product, ContraPest, is designed to control rodent populations by targeting reproductive processes rather than lethality, providing an environmentally friendly alternative to traditional pest control methods.
What is ContraPest?
ContraPest is SenesTech's flagship product, a fertility control solution for managing rodent populations. Unlike conventional rodenticides, ContraPest targets reproduction by disrupting the hormonal processes in rodents, ultimately reducing their numbers without employing lethal methods, which helps in promoting an ecologically responsible approach.
What is the goal of SenesTech?
The primary goal of SenesTech is to provide humane and effective methods for controlling rodent populations while reducing reliance on traditional toxic rodenticides. Through innovation and biotechnology, the company aims to enhance public health, protect agricultural and food resources, and promote environmental sustainability.
What is the long-term vision of SenesTech?
The long-term vision of SenesTech is to become a leader in sustainable pest management by continuously innovating and providing effective solutions that balance ecological health and pest control. The company aims to revolutionize the way we address pest populations by shifting the paradigm from lethal control to reproductive management.
What is the significance of SenesTech's ticker symbol, SNES?
The ticker symbol SNES represents SenesTech, Inc. on the Nasdaq stock exchange. This symbol is an identifier used by investors and analysts to trade shares of the company, reflecting its focus on innovative solutions in the pest management sector.
What is the status of SenesTech's FDA approval for ContraPest?
As of the latest updates, SenesTech is actively seeking regulatory approval for ContraPest from the appropriate governmental agencies. The company is committed to ensuring compliance with all safety and efficacy requirements laid out by the FDA and other regulatory bodies to facilitate market entry.
What kind of research does SenesTech engage in?
SenesTech engages in research focused on biotechnology and reproductive control, exploring various avenues in rodent management. This includes studies on the efficacy of ContraPest, anatomical research related to rodent reproduction, and environmental impact assessments to ensure that their solutions are safe and effective in diverse conditions.
What markets does SenesTech target?
SenesTech targets a variety of markets where rodent control is crucial, including agriculture, food production, urban areas, and public health. By providing an effective and humane solution to pest management, the company aims to meet the needs of both commercial and residential sectors.
When was SenesTech, Inc. founded?
SenesTech, Inc. was founded in 2015. The company emerged from the efforts of its founders, who aimed to create sustainable and humane solutions for managing pest populations, particularly rodents, through cutting-edge biotechnology.
Where is SenesTech, Inc. headquartered?
SenesTech, Inc. is headquartered in Flagstaff, Arizona. The location was chosen due to its access to key resources, talent pools, and research facilities that support the company's mission towards sustainable pest management solutions.
Who are the key leaders of SenesTech, Inc.?
SenesTech, Inc. is led by a team of experienced professionals with backgrounds in biotechnology, business development, and regulatory affairs. The management team includes a mix of scientists, industry veterans, and strategic thinkers who guide the company's vision and operations to achieve its goals in pest management.
What is the current price of SenesTech, Inc. - Common Stock?
The current price of SenesTech, Inc. - Common Stock is 1.764
When was SenesTech, Inc. - Common Stock last traded?
The last trade of SenesTech, Inc. - Common Stock was at 2:09 pm EDT on April 2nd, 2025
What is the market capitalization of SenesTech, Inc. - Common Stock?
The market capitalization of SenesTech, Inc. - Common Stock is 21.51M
How many shares of SenesTech, Inc. - Common Stock are outstanding?
SenesTech, Inc. - Common Stock has 12.19M shares outstanding.